Decisive Conditions for Strategic Vaccination against SARS-CoV-2
Lucas Böttcher, Jan Nagler
doi: https://doi.org/10.1101/2021.03.05.21252962
Lucas Böttcher
1Dept. of Computational Medicine, University of California, Los Angeles, CA 90095-1766, United States of America
2Computational Social Science, Frankfurt School of Finance & Management, Frankfurt am Main, 60322, Germany
Jan Nagler
3Deep Dynamics Group, Centre for Human and Machine Intelligence, Frankfurt School of Finance & Management, Frankfurt am Main, 60322, Germany
Article usage
Posted July 06, 2021.
Decisive Conditions for Strategic Vaccination against SARS-CoV-2
Lucas Böttcher, Jan Nagler
medRxiv 2021.03.05.21252962; doi: https://doi.org/10.1101/2021.03.05.21252962
Subject Area
Subject Areas
- Addiction Medicine (394)
- Allergy and Immunology (706)
- Anesthesia (197)
- Cardiovascular Medicine (2890)
- Dermatology (248)
- Emergency Medicine (433)
- Epidemiology (12635)
- Forensic Medicine (10)
- Gastroenterology (815)
- Genetic and Genomic Medicine (4498)
- Geriatric Medicine (411)
- Health Economics (719)
- Health Informatics (2877)
- Health Policy (1060)
- Hematology (381)
- HIV/AIDS (913)
- Medical Education (419)
- Medical Ethics (115)
- Nephrology (466)
- Neurology (4266)
- Nursing (228)
- Nutrition (626)
- Oncology (2236)
- Ophthalmology (637)
- Orthopedics (256)
- Otolaryngology (323)
- Pain Medicine (272)
- Palliative Medicine (83)
- Pathology (491)
- Pediatrics (1183)
- Primary Care Research (490)
- Public and Global Health (6846)
- Radiology and Imaging (1505)
- Respiratory Medicine (910)
- Rheumatology (431)
- Sports Medicine (378)
- Surgery (476)
- Toxicology (60)
- Transplantation (206)
- Urology (176)